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A method for the rapid preparation of a dcfincd substrate to monitor RNasc H activity has b.m dcvclopcd. Using this substrate. we have 
invcstigtcd the RNasc H activities of the diErent forms of recombinant HIV-I and HIV-2 rcvcrsc transcriptax (R’f, in dctaii. As WC rq-~~rt hm. 
RMasc H activity is associated only with the dimeric forms (p51@% or @/PI%) of the enzymes 
HIV: Rcvcrsc transcriptasc; RNdsc Hz Dimcrizalion 
1_ INTRODUCTION 
In addition to their DNA pu;ymerasc activity, retro- 
viral reverse transcriptases possess an RNase H activity 
which degrades the RNA moiety of an RNA/DNA 
hybrid. The RNase H actP;iu Is i,tirntial for the piocess 
of conversion of gcnctic information from the sinnlc 
stranded RNA form in the virion into the double 
stranded DNA form in infected rolls. Formally, during 
synthesis of the minus strand of DNA complementary 
tv the viral RNA gcnome, the RNAse H activity is 
required to degrade the RNA strand in the DNA/RNA 
hybrid to allow plus strand DNA synthesis. The actual 
mechanism appears to involve the simultnncous action 
of both the polymerase and RNasc H activities. so that 
as the DNA strand grows, the RNA tcmpbtc is 
degraded [I]. 
The rcver~ transcriptases of HIV-I and HIV-2 are 
hctcrodimeric proteins consisting of one subunit of mo- 
lecular weight of approximately 66 kDa and anothct of 
molecular weight of 51 kD:i, *.vhich ccprcscnts :I c&o- 
xytcrminaliy truncated form of the larger subunit [2--71. 
The diffcrencc polypcptidc between thcsc two subunits 
contains the RNAsc H activity of the rcversc 
transcriptasc [8,9]. There is still controversy rcgurding 
the biological significance of the dim& orgtmization. 
which is characteristic of the known lcntiviral RTs. In 
particular thcrc is no agrccmcnt about the signiticancc 
of the monomeric and homodimeric species which have 
been isolated from recombinant expression systems. 
Using recombinant enzyme preparations we have in- 
vestigated the biochemical properties of monomeric and 
dimcric forms of HIV-I and HIV-2 RT, We were parti- 
cularly intcrcstcd to determine whether the RNAse H 
activity is influenced by subunit interaction. WC 
describe hcrc experiments which clarify the dcpendcnce 
of the RNAsc H activity on the state of dimerization of 
the rcvcrse t~mscriptasc molecule. 
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togral~* on ~a ~. . -o te  cxdman tl-H[ .a,d 16x 10{) ram:, Phar- 
H ~ ~ ~" the ~Id ; t~ of'2 ~ ~f ~ffef C aod al~l~ed to 
~ in barter C ~ boend protein ~ dined ~- a step 
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pur i~ protein was tt~eu dlabTed ~ ."0 mM Tr~HCt. pH 7.S. 
l mM EDTA. i n~M DTI'. 15% ~ and xmred at -80~C. 
",2_" ~ n  of  ~ke lUCre H ~wme 
The #~d p l~Endo (pB]uescript KS comaining the coding se- 
quence for the ~ from HIV- I~)  m~s linearized v~h 
.WzoL r ~  ef DNA into RNA was carried out ip a total vol. 
of ~/d  containing 40 mM Tris-HCl pH 7.9. 6 mM Mg~l~ 2 mM 
cpermidi~e. I0 mM DTT. 100~ml  ~ 60 U gNmin  fl~omega). 
0.5 mM rNWP (GTP, ~ and ~ 0.05 mM ATP [=-~V]ATP. 400 
Ci~smol or [~H]ATP, 44 Cffmmc~: ~ t .  2-5 pg lincarized 
vector DNA m~1100 U 1"7 RNA pol3"memse {Nest, England Biolabs). 
Af-er 2 h at 37~ the rea~(~l was slopped by the addition of 20 mM 
EWrA a~l ~ us~g Qmagen ~ m  (aowrdl-g to the imtruc- 
t~ons of the manuraclUre~. D]apen; ~ . ,  Germany}. The 
RNA silts d~b:,h~d itl[D'blidizatkm l lTer (80~ formamidc. 
400 mM NaCL I mM EDTA. 50 mM HEPES pH 6.4} and the con, 
cemration tca~ cal,~dated from the amount of incoqxwated radioac. 
titity. The ~ i n g  DNA fragmem ~as amplified by PCR from 
the pla_~id pEtS- Endo using PCR primers hybridizing to the 1"3 and 
"I"7 promolor sequcnf~ reR0¢~h'eh,. PCR ¢~.ditiorrs were:. 67 mM 
Tris-HC]~ pH 8.8. 10% DMSO, 0.16 mg~ml BSA. 2 m M MgCi 2. 16 mM 
(NH,)>SO~. 7 mM .8,-ff~aI~s~LSmnoL 200 pM dNTP each. 0.4/~M 
primer, 15 pM rector and 2 U T~q DNA polymerase (Beckman) in 
a 50pl reaclion mixture. 40 ~ les  (I rain at g0~, I rain at ~ and 
10 rain at 7WC3 ~--r~ performed. The product ~ts purified by. HPLC 
gel filtration in 20 mM Tri.~HCI pH 7.5. 100 mM NaCI lcolumns 
2.5l. After ethanol precipitation, the fragment ~as dissoh'ed in TE 
b~affer and the concentration ~us delem~ined bymeasuring the ab- 
~rbar~ at ~ nm. Subsequently the DNA was lyophilized und 
tedis~oh'ed in 50pl hybridization buffer containing the labelled RN;. 
The molar ratio of RNA to the corr~ponding DNA strand was 1:3. 
The mixture ~us incubated for I 5 mln at 85~ follo~d by. 3 h at 55'C. 
To remove the formamide. ~c hybridi~tion mixture was ai~l~cd to 
a ~epharo~e (CL- 6B. Pharmacla) column and cluted with TE ( 10 mM 
Tris-HCi pH 7.8. !mM DTT) buffs. Digcstion of the final prepara- 
tio~ wi~h S! n t~ le~ 1~ to d.¢gradat~on ofca. 20% of,~e radicr,~ive!y 
labelled RNA to acid solub~ material sug_g~ting a comami~tation 
with single ~randed RNA. The remainM 8 80~ of the RNA could be 
o~rmi~qely degraded by. rcwc'rSc trar:crifft~e. 
2.3. Dewrmlnalian of the RNaw H at~iriCy 
The rcaciion f, oIution contained: .SO mM Tfi~-HO pH 8.0, gO mM 
KCI. gmM Mg~:~ ~ mM DTT. 0.! m~ml BSA. S ~:rno! RNA/DNA 
hybrid and on.'me. Rc~clion~ w~n~ i~batcd for 10 rain al 37"C and 
SlGpi~ by lhe addhjon of 2 ml ice.cold 5%, ttichlo~'o~c~if a~d. 
Ac~-inuflub~ n~nct~l ~as oollected on nht"~llul~-~e filters 
Lr'~hlcic'h~ and Schu~L BA 85~ and vgd~caivhv rc~ncJ on :h~ 
filtcr~ w-a~ w~urcd  by. ,~ntillation cou~ting~ i U o~" RNa~ H acli~ity 
l0 rain at 37~C. 
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~bmi~ed). l~et~,, mk~e were immunized ~h lmrified recm~binam 
HIV- I RT and ~uct i0n  of hy~0ma_s v,~ peffo~cd, as d~bed 
brkk,ma om ~tan~ ~ wen as rrc~ ~t~nid  ~ a  ~er -  
cially avaRable kit (MAPS 11[ kit. Bio.Rad) folk~-:-ng the Lnstm~ons 
ofthe maonfat~rer. All preparations were ~o~t  to be free of pro- 
tease ~t  ~ ~-'t~s~ E#to~ mapping was perrorme~ using 
a set 04" I I C-~em6nal de~km mutants of I-libel RT. The interaction 
of the antibodies with the truncated proteins was investigated by 
im~unoblotting [I~]. 
2.5. HPLC M=e e.xclu~ion ctlromorogral@y 
Chromatography was performed u.~g two HPLC columns in series 
{Bio-Rad TSK-250 foIlc~'ed by Bio-Rad TSK-125; both 7.5 × 300 
ram). The columns ~e elut~d ~th 200 mM potassium phosphate pH 
6.5 at ! refrain. 
3. RESULTS AND DISCUSSION 
For determination of the RNase H activity of HIV 
RT we developed a simple method for the rapid 
preparation of large amounts of a defined RNA/DNA 
hybrid as outlined in Fig. 1. The method is based on the 
production of a "runoff' RNA transcript of defined 
length by T7 polymera~, followed by hybridization to 
the complementary DNA strand. The DNA fragment 
was amplified by PCR and hybridization was carried 
out under conditions favouring formation of RNA/ 
DNA hybrids. The resulting hybrid, which was labelled 
uniformly with ['~H]- or [32P]ATP in the RNA strand, 
consisted of a 1043 base DNA strand derived from the 
HIV-I endonuelease sequence and a complementary 
RNA strand of 966 bases. The degradation of the RNA 
,, .w .__  
oto~t~ e9 mtt~b 
2 U 
F~_ I. P:~ralmn of lht" RNA~DNA hybrid. For d~ail~ ~c rnalc~a~ 
and ~l~d~.  The n~ulling hybrid ha~ Y- arm Y-DNA ot'ethanging 
evt~ of 53 and 24 b '~ rc~cti~ly.  
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Fig. 2. Comparison of the RNa.~ H activity of HIV-I (circles) and 
HIV.2 (squares) rcvcrs¢ transcriptase h terodimers as a function of 
the enzyme concentration. 
moiety of the hybrid was followed by the decrease of 
acid-precipitable radioactivity upon incubation with 
RT. 
The different forms of  HIV-I and HIV-2 RT were 
incubated with this substrate to determine their specific 
RNase H activities. Preparations of hetcrodimeric 
reverse transcriptase from HIV-1 had specific activities 
of  ca, 400 U/rag. The same activity was found for the 
dimeric form e f  the 66 kD- ~bun i t  of  r¢,erse 
transcriptase. It is o f  interest o note that recombinant 
reverse transeriptase from HIV-2 [7] exhibits a com- 
parable RNase H activity (Fig. 2), in contrast with 
earlier findings which suggested that the activity was i0 
times lower than in the case of  HIV-1 [15]. This activity 
arose exclusively from the recombinant protein, and not 
from contaminating E. coil RNase H, as proven by the 
result that it could be completely inhibited by a mono- 
clonal antibody (designated MAb 2; Fig. 3). This anti- 
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Fig. 3. Inhibition of HIV-i rcvcr~ tran~ripta~ RNa~ H activity by 
a purified monoclon:d antibody. See lext for delails. A prcincubation 
of enzyme and antibody was performed for ca. 10 minute~ on i~ 
~cf,,tc starting the reaction by adding ihe ~nbslrale, The amount of 
hctcrodimeric RT was held conslant at 20 ng. The 100% wd,¢ cor- 
responds toa specific uclivjty of 400 unil~mg. Circ~e~. 14IV- I: squares. 
HW-2. 
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Fig. 4. Specific RNa.~ H activity of HIV-t reverse transcriptase (p511 
p66) as a function of the degree ofdimerization. The hcterodimet was 
dissociated by tc~atmenl with 15% acctonitdle and rc-associalion was 
initiated by lowering the acetonitrile concentration to 3%. For details 
s¢¢ text and refs. [5,7]. RNas¢ H activity was measured throughout the 
course of redimerization a d the dimer content was determined in 
parallel by HPLC gel filtration. The 100% value corresponds toa 
specific activity of 400 U/rag. 
prepared against recombinant HIV, I RT [16; Restle et 
al., submitted] and has been shown to recognize an 
epitope located between amino acids 300 and 350 of the 
protein (for details see section 2). Since this antibody 
recognizes an epitope which is not part o f  the RNase H 
domain, it is evident that the inhibition cannot arise 
from cross reactivity with contaminating RNase H from 
other sources. HIV-2 RT, which does not cross react 
with this monoclonal antibody, shows no reduction of 
RNase H activity in a control experiment (Fig. 3). This 
demonstrates that the inhibition of  the HIV-! enzyme 
occurs in a specific manner. 
We have previously shown that the RNA-dependent 
DNA-polymerase activity of reverse transcriptas¢ from 
HIV-! and HIV-2 is only present in dimeric forms of the 
enzyme (51 kDa homodime:s, 66 kDa homodimers or 
66/51 kDa heterodimers) and that the monomeric forms 
show no activity [5,7]. The ,em,lts hown in Fig. 4 dem- 
onstrate that this is also true for the RNase H acfivi'~. 
As we have described c~rlier [5], dimer,~ HIV RT can 
be dissociated by the addition of  a~tonitri le. Upon 
reduction of  the organic solvent concentration by dilu- 
tion of the sample, slow (fl,., approximately 12 h at the 
concentration of  6 pM used here) quantitative re-as- 
sociation of  the subunits to the native heterodimer 
occurs. This re,association process can be studied in a 
time-dependent manner b) high resolution HFLC size 
exclusion chromatography. Using this technique we 
found that there is also a linear relationship between the 
degree of dimerization and the specific RNa~ H activ- 
ity o1 the RT he,erodimer (kig. 4). Similar results were 
obtained for the "~6 ~.l):~ r:-7:~trations (data nol shown). 
whereas neither the dimcric nor the monomeric form of 
the 51 kDa subunit sho~c~l detect~!ble activity. Prcpara- 
vi,:,ns of  rever~e transcriptase from HIV-2 showed simi- 
lar behaviour (data not shown). We therefore conch, It 
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c& st;L-ting with Phe- of the R-f coding sequemx was 
not ~IFOX&UL In contrast_ chosingT>F as the starting 
point $17J led to efficiezt eqmzision in the range of 
10-15sle of szduble protein The reaxabinant protein 
ws pufif%d a5 darni in section 2 Upon purification 
by FPLC gel filtmtion, the recombinant protein was 
separated intu two fraaiuns avhich appezed identical 
an SDS-PAGE. ?Bcse probably cornspond to mono- 
meric and dim&c fm of the protein with molecular 
weights of 16 and 30 kDa. rwpxtiwly. as verified by 
high resolutivn HPLC size exclusion chromatography. 
However. it was not possible to induce dissociation of 
the putative dimeric fom;n or ztssokation of the mono- 
meric fom by dilution or concentration of the protein 
soWion xqxctively. so that we telieve that they re- 
present forms of the protein which arr folded difK& 
em?\= Vety low &a. -5%fold lower than the reverse trans- 
criptase heterodimer) RNase H activity was detected in 
the monomeric form of the protein. This activity could 
not be inhibited by another monoclonal antibody (des- 
ignated MA5 I: [MZ. Restle ct al.. submitted) which 
recognizes an epitope in the RNase H region of HIV-I 
RT (epitope ~EBWIXTI amino acids 528 and 560) and was 
found to inhibit the RNasc H activity of the 6MS1 kDa 
hcterodimer to the extent of 20%. Thus. WC conclude 
thnt the enzymatic activity dcxcted in the monomerir 
form of the recombinant RNasc H domain probably 
atis- from contaminating &. cdi RNasc H. No atiivity 
could b+~ dcteclcd ifi thr: dimctic form. which is probably 
due to the fact that thr FPLC gel filtration column is 
able to sepatmte this fbrm from the E. c-o/i prolcin. which 
Rzrs 21 molecular wizight of nbout ts kDa. 
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